The Indian government is addressing concerns related to high trade margins on cancer medications. Pharmaceutical Secretary Manoj Joshi highlighted unethical practices occurring within the healthcare industry. He noted that hospitals often prefer expensive medicines that provide higher margins. Additionally, smaller manufacturers may engage in practices that create unethical relationships with doctors or retailers. Efforts are being made to improve the viability of government-run stores selling low-cost medicines.
